The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CHEMBL535150     3-[2-(phenethyl-propyl- amino)ethyl]phenol...

Synonyms: SureCN11650875, RU-24213, CTK8D4848, AR-1F1381, LS-105097, ...
This record was replaced with 114876.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 3-[2-(phenethyl-propyl-amino)ethyl]phenol

  • Long-lasting D2 receptor stimulation (8 days; 10 nM RU 24213) prevented this selective effect through activation of a pertussis toxin-sensitive G protein [1].

Psychiatry related information on 3-[2-(phenethyl-propyl-amino)ethyl]phenol

  • When, for comparison, the D2 agonist, RU 24213 (0.1-20 mg/kg IP), was tested for PE, SY, motor activity and SB, it displayed a behavioural pattern very similar to that obtained with SND 919 [2].

High impact information on 3-[2-(phenethyl-propyl-amino)ethyl]phenol

  • Prior incubation of rat anterior pituitary cells with 17beta-estradiol led to an almost complete reversal of the inhibitory effect of two dopamine agonists, dihydroergocornine and RU 24213, on both basal prolactin release and thyrotropin releasing hormone-induced prolactin release [3].
  • In contrast, incubation with the D2 agonists [LY 171555, (+)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, RU 24213] increased the soluble and decreased the particulate PKC activity [4].
  • Topographical effects of 0.3 to 10.0 mg/kg RU 24213, primarily induction of sniffing and ponderous locomotion with accompanying reductions in rearing, grooming, sifting and chewing, were not altered to any material extent in DARPP-32-null mice [5].
  • In contrast, quinpirole (1 mg/kg) and RU 24213 (3 mg/kg) produced more intense stereotypy consisting of rearing, sniffing and repetitive head movement in the two psychostimulant-treated groups than in the saline-treated group [6].
  • In both the NAc and CPu, the inhibition of neurons produced by iontophoresis of the D2 receptor agonists quinpirole or RU-24213 was attenuated by acute DA depletion via the tyrosine hydroxylase inhibitor alpha-methyl-p-tyrosine (AMPT) [7].

Biological context of 3-[2-(phenethyl-propyl-amino)ethyl]phenol


  1. Chronic stimulation of D2 dopamine receptors specifically inhibits calcium but not potassium currents in rat lactotrophs. Lledo, P.M., Israel, J.M., Vincent, J.D. Brain Res. (1991) [Pubmed]
  2. Behavioural evidence that different neurochemical mechanisms underly stretching-yawning and penile erection induced in male rats by SND 919, a new selective D2 dopamine receptor agonist. Ferrari, F., Pelloni, F., Giuliani, D. Psychopharmacology (Berl.) (1993) [Pubmed]
  3. Potent antidopaminergic activity of estradiol at the pituitary level on prolactin release. Raymond, V., Beaulieu, M., Labrie, F., Boissier, J. Science (1978) [Pubmed]
  4. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes. Giambalvo, C.T., Wagner, R.L. J. Neurochem. (1994) [Pubmed]
  5. Ethologically based resolution of D2-like dopamine receptor agonist-versus antagonist-induced behavioral topography in dopamine- and adenosine 3',5'-monophosphate-regulated phosphoprotein of 32 kDa "knockout" mutants congenic on the C57BL/6 genetic background. Nally, R.E., Kinsella, A., Tighe, O., Croke, D.T., Fienberg, A.A., Greengard, P., Waddington, J.L. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  6. D-2 but not D-1 dopamine agonists produce augmented behavioral response in rats after subchronic treatment with methamphetamine or cocaine. Ujike, H., Akiyama, K., Otsuki, S. Psychopharmacology (Berl.) (1990) [Pubmed]
  7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel, S.R., Hu, X.T., Galloway, M.P., White, F.J. Synapse (1989) [Pubmed]
  8. Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. Pizzi, M., Da Prada, M., Valerio, A., Memo, M., Spano, P.F., Haefely, W.E. Brain Res. (1988) [Pubmed]
  9. Profile of the selective dopamine D-2 receptor agonist N-0437: its effects on palatability- and deprivation-induced feeding, and operant responding for food. Rusk, I.N., Cooper, S.J. Physiol. Behav. (1988) [Pubmed]
WikiGenes - Universities